These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 28512758)
1. Reporting practices for unsolicited and secondary findings from next-generation sequencing technologies: Perspectives of laboratory personnel. Vears DF; Sénécal K; Borry P Hum Mutat; 2017 Aug; 38(8):905-911. PubMed ID: 28512758 [TBL] [Abstract][Full Text] [Related]
2. Reporting practices for variants of uncertain significance from next generation sequencing technologies. Vears DF; Sénécal K; Borry P Eur J Med Genet; 2017 Oct; 60(10):553-558. PubMed ID: 28774848 [TBL] [Abstract][Full Text] [Related]
3. Exploration of genetic health professional - laboratory specialist interactions in diagnostic genomic sequencing. Vears DF; Sénécal K; Borry P Eur J Med Genet; 2020 Mar; 63(3):103749. PubMed ID: 31472303 [TBL] [Abstract][Full Text] [Related]
4. Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories. Ackerman SL; Koenig BA AJOB Empir Bioeth; 2018; 9(1):48-57. PubMed ID: 29131714 [TBL] [Abstract][Full Text] [Related]
5. How do consent forms for diagnostic high-throughput sequencing address unsolicited and secondary findings? A content analysis. Vears DF; Niemiec E; Howard HC; Borry P Clin Genet; 2018 Oct; 94(3-4):321-329. PubMed ID: 29888485 [TBL] [Abstract][Full Text] [Related]
6. Points to consider for laboratories reporting results from diagnostic genomic sequencing. Vears DF; Sénécal K; Clarke AJ; Jackson L; Laberge AM; Lovrecic L; Piton A; Van Gassen KLI; Yntema HG; Knoppers BM; Borry P Eur J Hum Genet; 2018 Jan; 26(1):36-43. PubMed ID: 29184171 [TBL] [Abstract][Full Text] [Related]
8. Reporting incidental findings in genomic scale clinical sequencing--a clinical laboratory perspective: a report of the Association for Molecular Pathology. Hegde M; Bale S; Bayrak-Toydemir P; Gibson J; Jeng LJ; Joseph L; Laser J; Lubin IM; Miller CE; Ross LF; Rothberg PG; Tanner AK; Vitazka P; Mao R J Mol Diagn; 2015 Mar; 17(2):107-17. PubMed ID: 25684271 [TBL] [Abstract][Full Text] [Related]
9. Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Rehder C; Bean LJH; Bick D; Chao E; Chung W; Das S; O'Daniel J; Rehm H; Shashi V; Vincent LM; Genet Med; 2021 Aug; 23(8):1399-1415. PubMed ID: 33927380 [TBL] [Abstract][Full Text] [Related]
10. CCMG practice guideline: laboratory guidelines for next-generation sequencing. Hume S; Nelson TN; Speevak M; McCready E; Agatep R; Feilotter H; Parboosingh J; Stavropoulos DJ; Taylor S; Stockley TL; J Med Genet; 2019 Dec; 56(12):792-800. PubMed ID: 31300550 [TBL] [Abstract][Full Text] [Related]
11. Analysis of laboratory reporting practices using a quality assessment of a virtual patient. Vears DF; Elferink M; Kriek M; Borry P; van Gassen KL Genet Med; 2021 Mar; 23(3):562-570. PubMed ID: 33122805 [TBL] [Abstract][Full Text] [Related]
12. College of American Pathologists' laboratory standards for next-generation sequencing clinical tests. Aziz N; Zhao Q; Bry L; Driscoll DK; Funke B; Gibson JS; Grody WW; Hegde MR; Hoeltge GA; Leonard DG; Merker JD; Nagarajan R; Palicki LA; Robetorye RS; Schrijver I; Weck KE; Voelkerding KV Arch Pathol Lab Med; 2015 Apr; 139(4):481-93. PubMed ID: 25152313 [TBL] [Abstract][Full Text] [Related]
13. Controversy and debate on clinical genomics sequencing-paper 1: genomics is not exceptional: rigorous evaluations are necessary for clinical applications of genomic sequencing. Wilson BJ; Miller FA; Rousseau F J Clin Epidemiol; 2017 Dec; 92():4-6. PubMed ID: 28870871 [TBL] [Abstract][Full Text] [Related]
14. Is it research or is it clinical? Revisiting an old frontier through the lens of next-generation sequencing technologies. Bertier G; Cambon-Thomsen A; Joly Y Eur J Med Genet; 2018 Oct; 61(10):634-641. PubMed ID: 29704685 [TBL] [Abstract][Full Text] [Related]
16. Clinical application of amplicon-based next-generation sequencing in cancer. Chang F; Li MM Cancer Genet; 2013 Dec; 206(12):413-9. PubMed ID: 24332266 [TBL] [Abstract][Full Text] [Related]
17. The patient with 41 reports: Analysis of laboratory exome sequencing reporting of a "virtual patient". Vears DF; Elferink M; Kriek M; Borry P; van Gassen KL Genet Med; 2022 Jun; 24(6):1306-1315. PubMed ID: 35389343 [TBL] [Abstract][Full Text] [Related]
18. Managing the ethical challenges of next-generation sequencing in genomic medicine. Clarke AJ Br Med Bull; 2014 Sep; 111(1):17-30. PubMed ID: 25122627 [TBL] [Abstract][Full Text] [Related]
19. PathOS: a decision support system for reporting high throughput sequencing of cancers in clinical diagnostic laboratories. Doig KD; Fellowes A; Bell AH; Seleznev A; Ma D; Ellul J; Li J; Doyle MA; Thompson ER; Kumar A; Lara L; Vedururu R; Reid G; Conway T; Papenfuss AT; Fox SB Genome Med; 2017 Apr; 9(1):38. PubMed ID: 28438193 [TBL] [Abstract][Full Text] [Related]
20. Old Challenges or New Issues? Genetic Health Professionals' Experiences Obtaining Informed Consent in Diagnostic Genomic Sequencing. Vears DF; Borry P; Savulescu J; Koplin JJ AJOB Empir Bioeth; 2021; 12(1):12-23. PubMed ID: 33017265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]